Publisher's Synopsis
Blood-boosting Procrit is Johnson & Johnson's biotech superstar. Behind its various brand names, it ranks as Medicare's most reimbursed drug. But Procrit performs frighteningly well, and can stimulate so many blood cells that thousands of patients die in unexplained and painful ways. And that's not all: Cancer patients, who often receive injections, are never warned that the drug stimulates tumor growth, too, prompting one leading hematologist to dub it "Miracle-Gro for cancer.